Objective-The prevalence of insulin resistance (IR) is increasing worldwide because of increasing age, obesity, and physical inactivity. Emerging evidence supports a direct proatherogenic effect of IR on the coronary vasculature, but the relation between IR and angiographic atherosclerosis in a real-world clinical setting is uncertain. In this work, we assessed whether IR is independently associated with clinically significant angiographic atherosclerosis in nondiabetic individuals. Approach and Results-We examined the association between IR and the extent of coronary atherosclerosis determined by angiography in 1073 nondiabetic patients surviving acute myocardial infarction. Patients were divided into quartiles on the basis of the homeostasis model assessment grading of IR, and associations between IR and multivessel coronary artery disease, defined as ≥2 arteries with ≥70% stenosis (or ≥50% left main stenosis), were analyzed in bivariate and multivariable modeling. Overall, the cohort had a median age of 56 years; 28.9% women and 21.8% nonwhite. The crude prevalence of multivessel coronary artery disease was 37.8%, 42.3%, 47.2%, and 48.0% for homeostasis model assessment grading of IR quartiles 1, 2, 3, and 4, respectively (P trend =0.009). In multivariable modeling, compared with quartile 1, both quartile 3 (relative risk [95% confidence interval], 1.31 [1.07-1.60]) and quartile 4 (1.29 [1.03-1.60]) were independently associated with multivessel coronary artery disease. Covariates in the model included patient demographic and clinical characteristics and metabolic factors (low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, triglyceride, glycosylated hemoglobin, and high-sensitivity C-reactive protein). Conclusions-We demonstrate an independent association between IR and multivessel coronary artery disease in nondiabetic postmyocardial infarction patients. Our findings strengthen the experimental evidence for a direct atherogenic effect of IR independent of glucose control and other components of the metabolic syndrome. (Arterioscler Thromb Vasc Biol. 2013;33:2245-2251.) (J.A.S.). The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
I nsulin resistance (IR) is a hallmark of the metabolic syndrome and is the pathobiologic underpinning of type 2 diabetes mellitus. Although the details of the mechanism remain unknown, obesity defined by enlarged adipose tissue mass causes systemic IR. 1, 2 Thus, because of the global epidemic of obesity, decreasing physical activity, and the aging global population, the incidence of IR is rising rapidly. [3] [4] [5] Approximately 1 billion adults are currently overweight, and a further 475 million are obese. 6 In addition, >150 million school-aged children worldwide are overweight and 40 to 50 million are obese. 6 Multiple epidemiological studies have shown an association between IR and cardiovascular (CV) events in nondiabetic cohorts that is only partially accounted for by the components of the metabolic syndrome. [7] [8] [9] [10] [11] [12] Moreover, it has been suggested that IR may be linked to an increased risk of CV events independent of traditional risk factors. 13 Emerging in vitro evidence suggests that IR has direct proatherogenic effects at the level of the arterial wall, leading to a series of cellular events critical for plaque progression. 14, 15 Consistent with these experimental findings, investigators have reported an independent association between IR and carotid intimamedial thickness [16] [17] [18] [19] and coronary artery calcification, 20, 21 as indicators of early subclinical atherosclerosis, albeit indirect measures of coronary artery disease. Accordingly, data on the association between IR and the burden of clinically relevant coronary atherosclerosis are scarce, and whether this association is independent of other components of the metabolic syndrome have not been reported. The aim of the present study is to describe the relationship between IR and the extent of angiographic coronary atherosclerosis among survivors of acute myocardial infarction using the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) study. Beyond assessing whether this association is independent of other metabolic syndrome components, we also assessed its association independent of traditional atherosclerosis risk factors and inflammatory markers (C-reactive protein [CRP]).
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results
Overall, the cohort had median age of 56 years; 28.9% women; 21.8% nonwhite; 50.2% ST-elevation-myocardial infarction; Table 1 , stratified by sex-specific HOMA-IR quartiles. Subjects with more IR had higher body mass index (BMI) and were more likely to be on β-blockers, angiotensin-converting enzyme inhibitor, angiotensin receptor blockers, statins, or diuretics on arrival.
Smoking was less prevalent in the higher IR groups. There was no significant trend found in the arrival Killip class, left ventricular systolic function, duration of hospitalization, or Global Registry of Acute Coronary Events 6-month mortality score across increasing IR quartiles. The baseline metabolic characteristics are reported in Table 2 . Fasting plasma glucose, fasting plasma insulin (FPI), triglyceride, very low-density lipoprotein-cholesterol, glycosylated hemoglobin (HbA1c), and high-sensitivity CRP (hs-CRP) correlated with the degree of IR ( Figure 1 ). Coronary angiographic findings are shown in Table 3 . The prevalence of multivessel coronary artery disease (MVD) was 37.8%, 42.3%, 47.2%, and 48.0% for quartiles 1, 2, 3, and 4, respectively (P trend =0.009). After adjusting for traditional atherosclerosis risk factors, home cardiac medications, components of the metabolic syndrome, HbA1c, and hs-CRP, IR was independently associated with MVD ( Figure 2 Figure II in the online-only Data Supplement).
FPI has been used as a measure of IR, especially in nondiabetic patients. In our cohort, FPI is strongly correlated with HOMA-IR (r=0.95; P<0.001) and is independently associated with angiographic MVD (Figure 3 ). As compared with Q1 of FPI, Q3 had more MVD (RR [95% CI], 1.31 [1.07-1.59]), as did Q4 (RR [95% CI], 1.22 [0.99-1.51]). However, the magnitude of associations between quartiles of HOMA-IR and MVD was more robust than that between FPI and MVD. On the contrary, there is no correlation between HOMA-IR and HbA1c (r=0.03; P=0.4) and there is no association between HbA1c and MVD (P value for nonlinearity 0.13; Figure 2 ). As expected, IR is strongly associated with BMI, as a measure of obesity, in our cohort (Table 1 ). However, we did not identify any substantial interaction between HOMA-IR and BMI in association with MVD (P value=0.40 for the categorical interaction term), which indicated that the HOMA-IR/MVD relation did not differ substantially among the BMI subgroups. The assumption of linearity for BMI was assessed using restricted cubic splines. The P value for the nonlinear spline term of BMI was 0.89, indicating that there were no significant departures from linearity. Finally, hs-CRP was independently associated with MVD (RR [95% CI], 1.07 [1.01-1.14]). However, a test for interaction between HOMA-IR and hs-CRP was not significant (P=0.55).
Discussion
The relation between IR and atherosclerosis burden in a realworld clinical setting is uncertain. Here in the largest study yet to date, we demonstrated that IR, as measured by HOMA-IR, is associated with the extent of clinically relevant coronary atherosclerosis in nondiabetic patients, independent of the components of the metabolic syndrome, traditional atherosclerosis risk factors, and hs-CRP. We also demonstrated that this association was not BMI-related and did not differ substantially among the various BMI subgroups. Finally, we showed in our nondiabetic cohort that FPI is independently associated with angiographic MVD. However, this relation is not as robust as between HOMA-IR and MVD and, thus, favoring the use of HOMA-IR as an atherosclerosis risk predictor in epidemiological studies. There is accumulating evidence demonstrating an association between IR and increased carotid intimal-medial thickness, [16] [17] [18] [19] coronary calcification, 20, 21 and increased lipid content and plaque volume of nonculprit coronary lesions. 22 Taken in the context of this evidence and data from multiple large population studies showing that IR is associated with increased CV events (even after adjustment for components of the metabolic syndrome), [7] [8] [9] [10] [11] [12] this suggests that IR might be the common root of metabolic syndrome 23 and a mediator of the associated CV risk. 13 Emerging biological mechanisms support this association, particularly evidence supporting a direct proatherogenic effect of IR on the arterial wall. 14, 15, 24 In IR states, the anti-inflammatory and antiatherogenic effects mediated by endothelial production of nitric oxide through the phosphatidylinositol-3-kinase pathway are downregulated. [25] [26] [27] However, the mitogen-activated protein kinase pathway in endothelial and vascular smooth muscle cells and its multiple proatherogenic effects may be enhanced. [28] [29] [30] [31] In addition, insulin receptors are present on circulating monocytes and macrophages 32, 33 and are altered by IR states consequently promoting a series of cellular events critical for atherosclerotic plaque progression. 15, 34 In the setting of IR, the macrophage endoplasmic reticulum stress-apoptosis pathway is activated, leading to macrophage apoptosis in atherosclerotic lesions. 34, 35 This could be detrimental, especially that efferocytosis (the phagocytotic process that normally clears the apoptotic bodies in a manner that prevents postapoptotic inflammation and cellular necrosis) is also defective in the setting of IR. 15, 36 Thus, lesional macrophage apoptosis coupled with defective efferocytosis may lead to increased plaque necrosis and, ultimately, accelerated atherothrombotic vascular disease. 15 Another important finding in our study is that, despite that both HOMA-IR and hs-CRP were observed as independently associated with the burden of coronary atherosclerosis, there is no interaction evidence between the 2. Low-grade inflammation and IR are 2 key components that are interwoven in subjects with obesity and type II diabetes mellitus. A previous study has shown that in healthy, nondiabetic subjects, hs-CRP was positively associated with IR. 37 However, there is a lack of consensus on the cause-and-effect relationship between chronic exposure to low-grade inflammation and IR. Several experimental and epidemiological studies suggested a direct role of CRP in the initiation and progression of atherosclerotic lesions. 37 Our findings are in agreement with these observations but suggest that IR and hs-CRP may be pointing to 2 separate, although probably related, elements in the development of atherosclerosis and elevation of CV risk.
Our findings should, however, be interpreted in the context of the following potential limitations. First, we used HOMA-IR as an estimate of IR, which has several welldescribed limitations. 38 The best method for evaluating IR is the euglycemic hyperinsulinemic clamp technique, but its complexity and cost have limited its use, especially in the context of large pragmatic research studies. However, values derived using the HOMA-IR model of estimation correlate well with insulin sensitivity measured using a euglycemic clamp (r=0.88; P<0.0001). 39 Second, the state of IR measured could be transient and dependent on the stress of the acute illness. The fasting glucose and insulin values used in the present study were obtained from blood samples collected at or near the time of hospital discharge. This was done to minimize alterations in patients' metabolic profiles caused by transiently heightened adrenergic states at the time of their myocardial infarction and to be more reflective of the patients' chronic state. Nevertheless, some alteration caused by the postmyocardial infarction state cannot be entirely excluded. Third, nondiabetic patients in our cohort were identified on the basis of the history and using HbA1c values during hospitalization.
Fasting glucose values were also used as confirmatory tests.
Repeat tests of either the HbA1c or the fasting glucose, as recommended by the American Diabetes Association, to rule out laboratory error are not available. 40 However, the American Diabetes Association acknowledges that there are scenarios in which repeats of the same test are not available and relying on the results of 2 different tests (eg, fasting glucose and HbA1c), if concordant could be used for the diagnosis of diabetes mellitus. 40 Fourth, defining the burden of atherosclerosis as the number of epicardial vessels affected based on angiography might be too crude, a measure of atherosclerotic burden, especially given that these were provider-reported findings and not confirmed by an angiographic core laboratory. In addition, more detailed descriptions of the atherosclerotic lesions (eg, lesion length, minimum lumen diameter, presence of calcification or thrombus) are not available. Fifth, the difference we observed in our primary outcome was mostly in 2-vessel disease and not 3-vessel disease ( Table 3 ). There is a numeric, but not statistically significant, relationship between HOMA-IR and 3-vessel disease and this might be related to limited power of our study to detect differences in 3-vessel disease. Sixth, although the severity of an individual lesion is associated with its risk of rupture, studies have shown that most atherosclerotic plaques responsible for future acute coronary syndromes are angiographically mild. [41] [42] [43] Seventh, β-blockers are commonly used in the initial cohort and in our selected sample, and given the known effects of these drugs on blood glucose, the impact of this on our findings is not clear. Eighth, because of the observational nature of this investigation, the possibility of residual confounding cannot be completely eliminated, although we have adjusted for a broad range of metabolic derangements. Finally, our study is derived from cross-sectional data and one-point angiographic information, thus causality of relationship cannot be proven and our findings should be viewed as hypothesis generating only. Our findings are also derived from a highly selective sample of patients who had sustained an acute myocardial infarction, thus whether our observations are generalizable and could be extrapolated to other patient populations (eg, stable coronary artery disease, asymptomatic patients) needs to be studied.
Conclusions
In a large cohort of nondiabetic patients with acute myocardial infarction, IR is independently associated with an increased risk of multivessel coronary artery disease. This association is consistent with established experimental evidence and supports the direct effect of IR on CV tissues but does not demonstrate causality. Further studies are needed to better understand the role of IR in prevention and treatment of atherosclerosis in clinical practice.
